Nippon India Nifty Pharma ETF

Category: ETFs
Launch Date: 05-07-2021
Asset Class:
Benchmark: NIFTY Pharma TRI
Expense Ratio: 0.21% As on ( 31-05-2025)
Status: Open Ended Schemes
Minimum Investment: 1000.0
Minimum Topup: 0.0
Total Assets: 967.8 Cr As on ( 30-05-2025)
Turn over: 45
NAV as on 04-07-2025

22.8683

0.18 ( 0.8072% )

CAGR Since Inception

12.25%

NIFTY Pharma TRI 14.52%

PERFORMANCE of Nippon India Nifty Pharma ETF

Scheme Performance (%) Data as on - 04-07-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Nippon India Nifty Pharma ETF 11.41 22.99 - - 12.25
Nifty Pharma TRI 11.71 23.32 18.4 6.92 14.52
ETFs 7.72 20.14 20.09 12.7 13.79

Yearly Performance (%)

Fund Managers

Jitendra Tolani

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

RETURNS CALCULATOR for Nippon India Nifty Pharma ETF

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of Nippon India Nifty Pharma ETF

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Nippon India Nifty Pharma ETF 12.37 - -
ETFs - - - - - -
Market Cap Distribution

Small Cap

8.42%

Others

-0.01%

Large Cap

63.01%

Mid Cap

28.58%

PEER COMPARISION of Nippon India Nifty Pharma ETF

Period
Data as on - 04-07-2025
Scheme Name Launch
Date
1-Year
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Nippon India Nifty Pharma ETF 05-07-2021 11.41 22.99 0.0 0.0
Mirae Asset Hang Seng TECH ETF 06-12-2021 46.06 5.18 0.0 0.0
Nippon India ETF Hang Seng BeES 09-03-2010 38.82 9.02 3.86 4.53
Tata Gold Exchange Traded Fund 12-01-2024 32.61 0.0 0.0 0.0
ICICI Prudential Gold ETF 05-08-2010 32.6 21.38 14.04 12.67
Quantum Gold Fund 22-02-2008 32.59 21.28 13.91 12.67
Aditya Birla Sun Life Gold ETF 13-05-2011 32.53 21.28 14.03 12.82
Zerodha Gold ETF 03-02-2024 32.47 0.0 0.0 0.0
Mirae Asset Gold ETF 20-02-2023 32.46 0.0 0.0 0.0
SBI Gold ETF 28-04-2009 32.35 21.17 13.94 12.71

PORTFOLIO ANALYSIS of Nippon India Nifty Pharma ETF

Asset Allocation (%)